{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T05:41:07Z","timestamp":1698039667041},"reference-count":42,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2006,6,29]],"date-time":"2006-06-29T00:00:00Z","timestamp":1151539200000},"content-version":"vor","delay-in-days":5903,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Scand J Immunol"],"published-print":{"date-parts":[[1990,5]]},"abstract":"<jats:p>We have studied lepromatous leprosy (LL) as a human model disease for T\u2010cell non\u2010responsiveness to specific mycobacterial antigens and studied the effect of rlL\u20104, rIL\u20102, rlFN\u2010<jats:italic>y<\/jats:italic> and rTNF\u2010<jats:italic>x<\/jats:italic> thereon. T\u2010cell non\u2010responsiveness to <jats:italic>Mycobacierium bovis<\/jats:italic> bacillus Calmette\u2010Guerin (BCG) or purified protein derivative of <jats:italic>M. tuberculosis<\/jats:italic> (PPD) antigens could be overcome in 5 out of 8 non\u2010responder patients by rlL\u20102 and in 2 out of 8 by rlL\u20104. The ability of rIL\u20104 to overcome BCG\/PPD non\u2010responsiveness was strongly dose\u2010dependent. When rIL\u20102 and rIL\u20104 were added simultaneously, they seemed to synergize in their effect. T\u2010cell non\u2010responsiveness to <jats:italic>M. leprae<\/jats:italic> could be overcome only in 2 out of 18 non\u2010responders by rIL\u20102 but not by rIL\u20104 alone. The ability of rlL\u20102 to overcome T\u2010cell non\u2010responsiveness to <jats:italic>M. leprae<\/jats:italic> antigens became particularly marked when the recombinant 65\u2010kDa heat shock antigen of <jats:italic>M. leprae<\/jats:italic> was used instead of whole bacilli. Exogenously added rIL\u20104, and to a lesser extent rlL\u20102, strongly enhanced existing T\u2010cell responses to BCG or <jats:italic>M. leprae<\/jats:italic> in the majority (8 out of 11) of responders. These findings may have implications for the in vivo manipulation of the immune response by recombinant lymphokines and vaccines.<\/jats:p>","DOI":"10.1111\/j.1365-3083.1990.tb02806.x","type":"journal-article","created":{"date-parts":[[2006,6,30]],"date-time":"2006-06-30T21:58:59Z","timestamp":1151704739000},"page":"553-565","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A Comparative Study on the Effects of rIL\u20104, rIL\u20102, rIFN\u2010\u03b3, and rTNF\u2010\u03b1 on Specific T\u2010Cell Non\u2010Responsiveness to Mycobacterial Antigens in Lepromatous Leprosy Patients in Vitro"],"prefix":"10.1111","volume":"31","author":[{"given":"T. H. M.","family":"OTTENHOFF","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"WONDIMU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. N. B.","family":"REDDY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,6,29]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/5.4.765"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1984.tb00493.x"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.168.2.675"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(87)90015-3"},{"key":"e_1_2_1_6_2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.4049\/jimmunol.141.2.504","article-title":"IL4\/B\u2010cell stimulatory factor\u20101 stimulates T cell growth by an IL2 independent mechanism","volume":"131","author":"Brown M.","year":"1988","journal-title":"J. Immunol."},{"key":"e_1_2_1_7_2","first-page":"263","article-title":"The development of a vaccination model using two microorganisms and its application in leprosy and leishmaniasis","volume":"57","author":"Convit J.","year":"1986","journal-title":"Lepr. Rev."},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.168.2.543"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/330259a0"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1984.tb00495.x"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.155.3.914"},{"key":"e_1_2_1_12_2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1128\/iai.56.3.660-664.1988","article-title":"Recombinant interleukin\u20102 limits the replication of Mycobacterium lepraemurium and Mycobacterium bovis BCG in mice","volume":"56","author":"Jeevan A.","year":"1988","journal-title":"Infect. Immun."},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.169.3.893"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.162.3.917"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.162.1.381"},{"key":"e_1_2_1_16_2","first-page":"461","article-title":"HeterologOus expression of the 65 kilo dalton antigen of Mycobacterium leprae and murine T cell responses to the gene product","volume":"56","author":"Lamb F.I.","year":"1988","journal-title":"Inf. Immun."},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.7.2061"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.167.2.598"},{"key":"e_1_2_1_19_2","first-page":"73","volume-title":"Tolerance Workshop","author":"Malkovsky M.","year":"1986"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(84)90074-4"},{"key":"e_1_2_1_21_2","unstructured":"Malkovsky M. Sondel P.M. Strober W.&DaIgleish A.C.The interleukins in acquired disease. Submitted for publication 1990."},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/322459a0"},{"key":"e_1_2_1_23_2","doi-asserted-by":"crossref","first-page":"570","DOI":"10.4049\/jimmunol.138.2.570","article-title":"T cell defect in lepromatous leprosy is reversible in vitro in the absence of exogenous growth factors","volume":"138","author":"Mohagheghpour N.","year":"1986","journal-title":"J. Immunol."},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112194"},{"key":"e_1_2_1_25_2","first-page":"207","article-title":"Reversal of T cell unresponsiveness in lepromatous leprosy","volume":"57","author":"Nath I.","year":"1986","journal-title":"Lepr. Rev."},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198607033150102"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.168.5.1947"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830190421"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/322462a0"},{"key":"e_1_2_1_30_2","first-page":"419","article-title":"Unresponsiveness to Mycobacterium leprae in lepromatous leprosy in vitro: reversible or not","volume":"52","author":"Oltenhoff T.H.M.","year":"1984","journal-title":"Int. J. Lepr."},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/319066a0"},{"key":"e_1_2_1_32_2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev.iy.05.040187.002241","article-title":"B\u2010cell stimulatory factor 1\/interleukin\u20104","volume":"5","author":"Paul W.E.","year":"1987","journal-title":"Ann. Rev. Immunol."},{"key":"e_1_2_1_33_2","first-page":"455","article-title":"In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non\u2010mycobacterial stimulants","volume":"50","author":"Reitan L.J.","year":"1982","journal-title":"Int. J. Lepr."},{"key":"e_1_2_1_34_2","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.4049\/jimmunol.138.6.1786","article-title":"lmmunoregulalory activity of recombinant human tumor necrosis factor (TNF)\u2010alpha: induction of TNF receptors on human T cells and TNF alpha mediated enhancement of T cell responses","volume":"138","author":"Scheurich P.","year":"1987","journal-title":"J. Immunol."},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1988.tb00741.x"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(88)90109-8"},{"key":"e_1_2_1_37_2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4049\/jimmunol.141.1.29","article-title":"IL4 inhibits 1L2 mediated induction of human lymphokine activated killer cells but not the generation of antigen specific cytotoxic T lymphocytes in mixed leucocyte cultures","volume":"141","author":"Spits H.","year":"1988","journal-title":"J. Immunol."},{"key":"e_1_2_1_38_2","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.4049\/jimmunol.139.4.1142","article-title":"Recombinant interleukin 4 promotes the growth of human T cells","volume":"139","author":"Spits H.","year":"1987","journal-title":"J. Immunol."},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1988.tb00744.x"},{"key":"e_1_2_1_40_2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.4049\/jimmunol.140.2.531","article-title":"Enhancement of antigen and mitogen induced human T lymphocyte proliferation by tumor necrosis factor","volume":"140","author":"Yokota S.","year":"1988","journal-title":"J. Immunol."},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.16.5894"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(87)90168-X"},{"key":"e_1_2_1_43_2","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.4049\/jimmunol.138.12.4275","article-title":"Evidence for effects of inierleukin\u20104 (B cell stimulatory factor l) on macrophages: enhancement of antigen presenting ability of bone marrow derived macrophages","volume":"138","author":"Zlolnik A.","year":"1987","journal-title":"J. Immunol."}],"container-title":["Scandinavian Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-3083.1990.tb02806.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-3083.1990.tb02806.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T17:23:24Z","timestamp":1697995404000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-3083.1990.tb02806.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1990,5]]}},"alternative-id":["10.1111\/j.1365-3083.1990.tb02806.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-3083.1990.tb02806.x","archive":["Portico"],"relation":{},"ISSN":["0300-9475","1365-3083"],"issn-type":[{"value":"0300-9475","type":"print"},{"value":"1365-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,5]]},"assertion":[{"value":"2006-06-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}